Autophagy promotes citrullination of VIM (vimentin) and its interaction with major histocompatibility complex class II in synovial fibroblasts.


Journal

Autophagy
ISSN: 1554-8635
Titre abrégé: Autophagy
Pays: United States
ID NLM: 101265188

Informations de publication

Date de publication:
05 2020
Historique:
pubmed: 6 9 2019
medline: 8 6 2021
entrez: 6 9 2019
Statut: ppublish

Résumé

We aimed to investigate the involvement of macroautophagy/autophagy in autoimmunity in rheumatoid arthritis (RA) through citrullination of VIM (vimentin) and its interaction with MHC class II in synovial fibroblasts (SFs). The cell surface expression of MHC class II and B7 costimulatory molecules on SFs was analyzed by flow cytometry after treatment with IFNG/IFN-γ (interferon gamma). Intracellular citrullinated autoantigens in SFs were analyzed by immunoblotting using serum from anti-citrullinated peptide antibodies (ACPA)-positive patient as a primary antibody. SFs were incubated in serum-free medium or treated with proteasome inhibitor MG132 to induce autophagy. An autophagy inhibitor 3-methyladenin (3-MA) was used. Intracellular citrullinated VIM (cVIM) was evaluated by immunoblotting and immunocytochemistry. The interaction between MHC class II and cVIM was evaluated with co-immunoprecipitation and proximity ligation assay (PLA). We demonstrated that MHC class II, CD274/B7-H1 and PDCD1LG2/B7-DC were expressed on SFs following treatment with IFNG whereas CD276/B7-H3 was detected on SFs regardless of the presence of IFNG. ACPA-positive sera recognized a 54 kDa protein in SFs. By immunoprecipitation, the 54 kDa protein recognized by RA sera was revealed to be cVIM. Following induction of autophagy, intracellular cVIM was increased in SFs but the effect was canceled by 3-MA. The interaction between MHC class II and cVIM was demonstrated by co-immunoprecipitation. Furthermore, PLA revealed the significant increase of MHC class II-cVIM interaction following induction of autophagy. Our findings suggest that SFs may contribute to the autoimmunity in RA through citrullination of VIM and its interaction with MHC class II promoted by autophagy.

Identifiants

pubmed: 31486697
doi: 10.1080/15548627.2019.1664144
pmc: PMC7144877
doi:

Substances chimiques

Histocompatibility Antigens Class II 0
Vimentin 0
Citrulline 29VT07BGDA

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

946-955

Références

Arthritis Rheumatol. 2015 Feb;67(2):396-407
pubmed: 25330932
Ann Rheum Dis. 2010 Feb;69(2):345-51
pubmed: 19648126
Annu Rev Immunol. 2008;26:651-75
pubmed: 18173373
Nat Immunol. 2001 Mar;2(3):269-74
pubmed: 11224528
Clin Exp Rheumatol. 2007 Jul-Aug;25(4):599-604
pubmed: 17888217
Arthritis Rheumatol. 2014 Jun;66(6):1482-91
pubmed: 24497204
Nat Rev Immunol. 2002 Feb;2(2):116-26
pubmed: 11910893
Cell. 2010 Feb 5;140(3):313-26
pubmed: 20144757
J Clin Invest. 2015 Jan;125(1):42-6
pubmed: 25654549
Gut. 2011 Dec;60(12):1739-53
pubmed: 21300624
Autophagy. 2013 Oct;9(10):1449-50
pubmed: 23800703
J Exp Med. 2013 Nov 18;210(12):2569-82
pubmed: 24190431
Chem Rev. 2015 Jun 10;115(11):5413-61
pubmed: 25970731
Immunology. 1994 Jun;82(2):268-74
pubmed: 7927499
Nat Med. 2007 May;13(5):619-24
pubmed: 17450150
Arthritis Rheum. 2011 Oct;63(10):2873-83
pubmed: 21567378
FASEB J. 2012 Apr;26(4):1400-12
pubmed: 22247332
Arthritis Rheum. 2008 Jan;58(1):36-45
pubmed: 18163519
Arthritis Rheum. 2010 Jul;62(7):1870-80
pubmed: 20506224
Immunol Rev. 2010 Jan;233(1):34-54
pubmed: 20192991
Nat Rev Rheumatol. 2013 Jan;9(1):24-33
pubmed: 23147896
Ann Rheum Dis. 2012 Feb;71(2):245-8
pubmed: 22110122
Mol Immunol. 2018 Jul;99:163-170
pubmed: 29787980
Nat Rev Rheumatol. 2011 Jun 07;7(7):391-8
pubmed: 21647203
Diabetes. 2007 Apr;56(4):930-9
pubmed: 17395740
Nat Genet. 2003 Aug;34(4):395-402
pubmed: 12833157
Clin Rheumatol. 2012 Feb;31(2):271-81
pubmed: 21833687
Ann Rheum Dis. 2004 Apr;63(4):373-81
pubmed: 15020330
Cell. 2011 Nov 11;147(4):728-41
pubmed: 22078875
Arthritis Rheum. 2003 Oct;48(10):2741-9
pubmed: 14558078
Front Immunol. 2016 Dec 12;7:550
pubmed: 28018338
Nat Rev Rheumatol. 2017 Feb;13(2):79-86
pubmed: 27974851
Arthritis Rheum. 2008 Oct;58(10):3009-19
pubmed: 18821669
Immunity. 2007 Jan;26(1):79-92
pubmed: 17182262
Arthritis Rheum. 2010 Jan;62(1):117-25
pubmed: 20039411
Immunol Lett. 1997 Jun;58(1):53-8
pubmed: 9436470
ACS Chem Biol. 2016 Mar 18;11(3):654-68
pubmed: 26686581
Arthritis Rheumatol. 2014 Jan;66(1):40-8
pubmed: 24449574
Arthritis Rheum. 2007 Aug;56(8):2503-11
pubmed: 17665451
J Immunol. 2008 Mar 1;180(5):2989-98
pubmed: 18292521
Cell Death Differ. 2005 Nov;12 Suppl 2:1519-27
pubmed: 16247499
J Exp Med. 2011 Dec 19;208(13):2625-32
pubmed: 22162830
Lancet. 1998 Oct 3;352(9134):1137-40
pubmed: 9798608
Rheumatology (Oxford). 2005 Aug;44(8):1056-60
pubmed: 15901902
Clin Dev Immunol. 2013;2013:474028
pubmed: 23573111
Arthritis Res Ther. 2019 Jan 29;21(1):39
pubmed: 30696478
Proc Natl Acad Sci U S A. 2005 May 31;102(22):7922-7
pubmed: 15894616
Arthritis Rheum. 2010 Sep;62(9):2569-81
pubmed: 20872595
Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12640-5
pubmed: 15314238
Nat Rev Neurosci. 2015 Jun;16(6):345-57
pubmed: 25991442

Auteurs

Eri Sugawara (E)

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Masaru Kato (M)

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Yuki Kudo (Y)

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Wenshi Lee (W)

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Ryo Hisada (R)

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Yuichiro Fujieda (Y)

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Kenji Oku (K)

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Toshiyuki Bohgaki (T)

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Olga Amengual (O)

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Shinsuke Yasuda (S)

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Tomohiro Onodera (T)

Department of Orthopedic Surgery, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Shigetsugu Hatakeyama (S)

Department of Biochemistry, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Tatsuya Atsumi (T)

Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine and Graduate School of Medicine, Hokkaido University, Sapporo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH